osakeparin
Osakeparin is a low-molecular-weight heparin (LMWH) anticoagulant derived from unfractionated heparin through a chemical or enzymatic depolymerization process. It is primarily used in the prevention and treatment of venous thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Osakeparin belongs to the class of medications known as anticoagulants, which work by inhibiting the activity of clotting factors in the blood, thereby reducing the risk of clot formation.
The drug is administered via subcutaneous injection and is commonly prescribed for patients undergoing surgical procedures,
Like other LMWHs, osakeparin offers several advantages, including a longer half-life, more predictable anticoagulant effects, and
Osakeparin is not interchangeable with other LMWHs, such as enoxaparin or dalteparin, and dosage adjustments may